The article published by Mendoza et al.1 reaffirms the need to conduct mass testing to detect the new variants of SARS-CoV-2, and requests that the population remain cautious even after testing negative for infection. In this article, we emphasize the need to guarantee access to mass testing among symptomatic patients considering the presence of vulnerable populations particularly in low- and middle-income countries.